HLA I类分子细胞表面表达作为年轻血小板的标志物
该研究通过流式细胞术评估HLA I/MHC I分子在血小板表面的表达水平,发现高表达MHC I的血小板同时具有更高的噻唑橙染色和核糖体P抗原含量;小鼠输血实验显示年轻血小板表面MHC I分子数随血小板老化而下降,24小时内降至基础水平;在血小板减少症患者中,流式检测HLA I表达水平比噻唑橙染色或血液分析仪更准确地识别年轻血小板。
要点
- 高表达MHC I的血小板同时显示更高的噻唑橙染色和核糖体P抗原含量。
- 小鼠输血实验显示年轻血小板表面MHC I分子数随老化下降,24小时内降至基础水平。
- 血小板减少症患者中,流式检测HLA I表达比噻唑橙染色或血液分析仪更准确识别年轻血小板。
核心结论
- MHC I/HLA I表达可作为识别年轻血小板的有价值参数。
研究设计与样本
- 研究通过流式细胞术对血液进行噻唑橙和抗HLA I/MHC I抗体共染色后评估HLA I/MHC I表达。
- 研究包含小鼠输血实验以观察血小板老化过程中MHC I分子数的变化。
- 研究纳入血小板减少症患者,比较流式检测HLA I表达、噻唑橙染色和血液分析仪识别年轻血小板的准确性。
主要发现
- 高表达质膜MHC I分子的血小板显示增加的噻唑橙染色和更高的核糖体P抗原含量。
- 小鼠输血实验显示年轻小鼠血小板表面表达的MHC I分子数在血小板老化过程中下降,24小时内达到基础水平。
- 血小板减少症患者中,流式细胞术测定HLA I表达水平比噻唑橙染色或血液分析仪更好地识别年轻血小板。
临床怎么用
- 作者认为MHC I/HLA I表达是识别年轻血小板的有价值参数。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate identification of the proportion of young platelets is important to distinguish peripheral thrombocytopenia from a deficit in platelet production. Young platelets are defined by their higher RNA content and are often assessed as thiazole orange bright (TObright ) by flow cytometry. In clinical practice, their proportion is estimated by automatic blood counter according to their greater RNA content, which identifies a so-called immature platelet fraction (IPF). However, the detected IPFs are not strictly identical to the young TObright platelet population observed by flow cytometry. OBJECTIVES: The aim of this study was to assess the reliability of HLA I/major histocompatibility I (MHC I) cell surface expression as a marker of young platelets. METHODS: The HLA I/MHC I expression was evaluated by flow cytometry after costaining blood with TO and antibodies directed against HLA I/MHC I molecules. RESULTS: We found that platelets with a higher expression of plasma membrane-localized MHC I molecules displayed an increased TO staining and a higher content in ribosomal P-antigen. Transfusion experiments in mice showed that the number of MHC I molecules expressed on the cell surface of young murine platelets decreased during platelet aging, reaching basal levels within 24 h. Finally, we demonstrated that for patients with thrombocytopenias, the identification of young platelets is better assessed by the flow cytometric determination of the level of HLA I expression than by TO staining or the use of hematological blood counter. CONCLUSION: Overall, our results highlight the relevance of MHC I/HLA I expression as a valuable parameter to identify young platelets.
引用
- Angénieux C, Dupuis A, Gachet C, et al. Cell surface expression of HLA I molecules as a marker of young platelets. J Thromb Haemost. 2019. PMID: 31207003. doi:10.1111/jth.14537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。